Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Boehringer Ingelheim
US Army
Harvard Business School

Generated: July 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078718

« Back to Dashboard
NDA 078718 describes DEFEROXAMINE MESYLATE, which is a drug marketed by Watson Labs, Fresenius Kabi Usa, Hospira, and West-ward Pharms Int, and is included in four NDAs. It is available from two suppliers. Additional details are available on the DEFEROXAMINE MESYLATE profile page.

The generic ingredient in DEFEROXAMINE MESYLATE is deferoxamine mesylate. There are seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the deferoxamine mesylate profile page.

Summary for NDA: 078718

Formulation / Manufacturing:see details

Pharmacology for NDA: 078718

Mechanism of ActionIron Chelating Activity

Suppliers and Packaging for NDA: 078718

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
deferoxamine mesylate
INJECTABLE;INJECTION 078718 ANDA Fresenius Kabi USA, LLC 63323-597 63323-597-10 1 VIAL in 1 BOX (63323-597-10) > 5.3 mL in 1 VIAL
deferoxamine mesylate
INJECTABLE;INJECTION 078718 ANDA Fresenius Kabi USA, LLC 63323-599 63323-599-30 1 VIAL in 1 BOX (63323-599-30) > 21.1 mL in 1 VIAL

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength500MG/VIAL
Approval Date:Sep 15, 2009TE:APRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength2GM/VIAL
Approval Date:Sep 15, 2009TE:APRLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
US Department of Justice
Federal Trade Commission
Daiichi Sankyo
US Army
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:

Google Plus